Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs.

Jessica R BoxMark A OyamaAriel S MosencoRebecka S Hess

Published in: Journal of veterinary internal medicine (2024)

Canagliflozin may have a role in improving glycemic control in insulin-treated diabetic dogs, but the dose of insulin should be decreased when adding canagliflozin to insulin treatment.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
wound healing
metabolic syndrome
blood pressure
adipose tissue